Article
SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain…
medRxiv · 2021 · Jeroen Pollet
Key facts
| Title | SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice |
|---|---|
| First author | Jeroen Pollet |
| Journal | medRxiv |
| Published | Feb 9, 2021 |
| DOI | 10.1101/2020.11.04.367359 |
| Devices mentioned | K121894 |
| Product codes mentioned | MVU, NSU, PCH |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1